Wednesday, January 27, 2021

Wednesday poem: Chemistry Anonymous, Claire Burch

CHEMISTRY ANONYMOUS

The chemistry of war is hard to know. 
Mysterious. I never saw it grow. 
I only saw its dark results one morning, 
there is a lot to learn
I am learning

The chemistry of war makes fun of others, 
it curls white tired lips and shouts dry anger
to the small chemistry of low and hunger
and the mock turtle fiction that men are brothers.

"Nothing is lost but that it shall be found, nothing is crumpled but that it shall rise." 
All false. 
Go find small comfort in the ground
or in a greater chemistry! He dies 
who does not whisper laughter and does not see, 
and has no hands to touch, no feet to walk. 

There is no mystery but that of wrong
on the long shadowed beaches 
of the young. 

Claire Burch

Chemical Activity Barometer up 1.5% in December

From the American Chemistry Council: 

WASHINGTON (January 26, 2021) – The Chemical Activity Barometer (CAB), a leading economic indicator created by the American Chemistry Council (ACC), rose 1.5% in January on a three-month moving average (3MMA) basis following a 1.3% increase in December. On a year-over-year (Y/Y) basis, the barometer rose 1.3% in January.

The unadjusted data show a 1.2% gain in January, accelerating from a 0.4% increase in December. The diffusion index climbed to 79% in January from 71% in December. The diffusion index marks the number of positive contributors relative to the total number of indicators monitored. The CAB reading for December was revised upward by 1.02 points and that for November was revised upward by 0.94 points. As always, the January data are provisional and subject to revision.

“With nine months of gains, the latest CAB reading is consistent with expansion in the U.S. economy,” said Kevin Swift, chief economist at ACC.

The CAB has four main components, each consisting of a variety of indicators: 1) production; 2) equity prices; 3) product prices; and 4) inventories and other indicators.

In January, production-related indicators were positive. Trends in construction-related resins and related performance chemistry were solid and suggest further gains in housing, a sector that has performed well during the COVID-19 recession. Reflecting strength in light vehicles and new business investment, resins and chemistry used in other durable goods were strong. Gains in plastic resins used in packaging and for consumer and institutional applications were positive. Performance chemistry for industry was strong, reflecting a strong manufacturing sector. U.S. exports were positive, while equity prices increased. Product and input prices were positive, as were inventory and other supply chain indicators.

Good news for the housing and automotive sectors. Best wishes to all of us. 

Japanese drugmaker reports major product contamination issue in December

 Via FiercePharma in December: 

A "grave" manufacturing error in Japan tainted antifungal tablets with high doses of a sleep medication, leading to the death of one woman in her 70s and side effects in hundreds more people. 

Kobayashi Kako, the drugmaker behind the mix-up, said employees may have failed to follow company procedure when removing and mixing ingredients for the two highly divergent drugs, Osaka newspaper Asahi Shimbun reported.

The woman passed away Dec. 10 at a Tokyo-area hospital after taking Kobayashi's antifungal drug Itraconazole 50 Meek, the newspaper said.

The company's own investigation revealed 5 milligrams of a sleep med—identified by The Mainichi Shimbun as rilmazafone hydrochloride hydrate—had been added to each problematic tablet of Itraconazole 50 Meek. That amount is two-and-a-half times what's typically included in a single rilmazafone pill...

...To prevent these sorts of mistakes, Kobayashi said it keeps its drug ingredients in clearly differentiated containers. Components for its athlete's foot med go in a pulp-based, drum can-shaped container a little less than 3 feet tall, while its sleep med is stored in a flat box that clearly bears the drug's name. The company also requires two employees to work as a team when drug ingredients are removed and mixed.

Thing is, it didn't always work out this way. There was a period when a single staffer performed that task, Kobayashi Kako admitted to Asahi Shimbun. It suspects the mix-up may have happened then. 

This is a reminder of how simple errors can have profound negative consequences, and seemingly clear distinctions can apparently be missed. 

Tuesday, January 26, 2021

The 2021 Faculty Jobs List: 259 research/teaching positions and 31 teaching faculty positions

The 2021 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 259 research/teaching positions and 31 teaching assistant professor positions.

Want to help out? Here's a Google Form to enter positions.

In 2020-2021, we will be adding teaching professor positions, targeting positions that demonstrate an intention to renew permanently, 3 year terms and a promotion ladder and/or are titled "assistant teaching professor" or "associate teaching professor." We are adding community college positions if they explicitly offer tenure.

On January 28, 2020, the 2020 Chemistry Faculty Jobs List had 526 research/teaching positions and 56 teaching faculty positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

Want to talk anonymously? Have an update on the status of a job search? Go to the fourth open thread. Here's the third open thread, which closed on January 20, 2021. Click here for the second thread, which closed on December 22. Don't forget to click on "load more" below the comment box for the full thread. 

Postdoctoral position: decarbonylative cross-coupling, Szostak Lab, Rutgers University, Newark, NJ

From the inbox: 

Project: Decarbonylative Cross-Coupling 

Applications  are  invited  for  a  post-doctoral  position  available  to  start  in  April  2021 or  as  soon  as  possible at the Department of Chemistry at Rutgers University, Newark, USA working on Decarbonylative  Cross-Coupling  under  the  supervision  of  Prof.  M.  Szostak. The  project involves  industrial  collaboration  and is focused on the development of decarbonylative cross-coupling methods. The post is available  for  an initial fixed-term period of 12 months with a possible extension subject to funding. 

Send your CV, together with a cover letter and contact details of at least three referees to Prof. Szostak at  michal.szostak@rutgers.edu The  successful  applicant  will  have  experience  in  catalysis  and  cross coupling.  Only  applications  from  candidates  with  prior  experience  in  organometallic  chemistry  and  catalysis  will  be  considered.  Interested  applicants  should  contact  Prof.  Szostak  at  michal.szostak@rutgers.edu for additional details. Review of applications will begin immediately.  

Full ad here. Best wishes to those interested.  

The Chemical Engineering Faculty Jobs List: 50 positions

The Chemical Engineering Faculty Jobs List has 50 positions. It is curated by Lilian Josephson (@lljosephson).

From Dr. Josephson: This year we will try to utilize the list further by circulating among the professors, as well as using the hashtags #facultychemEjobs and #MeettheCandidatesChE2020.

The open thread is found here. 

The Academic Staff Jobs List: 91 positions

The Academic Staff Jobs list has 91 positions.

This list is curated by Sarah Cady and @nmr_chemist. It targets:
  • Full-time STAFF positions in a Chem/Biochem/ChemE lab/facility at an academic institution/natl lab
  • Lab Coordinator positions for research groups or undergraduate labs 
  • and for an institution in Canada or the United States
Want to help out? Here's a Google Form to enter positions.

Want to chat about staff scientist positions? Try the open thread.

Monday, January 25, 2021

Department of Justice indicts DuPont, DuPont plant management

Via the Associated Press: 

HOUSTON (AP) — A chemical company and a former employee have been indicted for their roles in a 2014 poisonous gas leak that killed four workers at a Houston-area plant, federal prosecutors announced Tuesday.

Four employees at the now-closed DuPont chemical plant in LaPorte, Texas, died in the release of methyl mercaptan — a chemical used in the manufacture of insecticide and fungicide.

A federal indictment issued earlier this month and made public Tuesday accuses DuPont and Kenneth Sandel of knowingly failing to implement certain company safety procedures required by federal regulations. Sandel, 49, ran the unit at the plant where the employees who died worked and was responsible for ensuring unit workers followed applicable federal safety regulations, according to U.S. Attorney Ryan Patrick.

In a statement, Corteva, a spinoff that took over DuPont’s agriculture division, said the company “will never forget the colleagues we lost and will continue to honor their memory.”

“We strongly disagree with the basis of the U.S. Attorney’s Office for the Southern District of Texas’ decision to bring criminal charges and will contest the charges vigorously,” said Wilmington, Delaware-based Corteva.

In a statement, Amy Craig and Miles Ehrlich, Sandel’s attorneys, said their client “did not cause this accident and he did nothing wrong. Charging him with a crime compounds the tragedy of this case. Ken Sandel is absolutely innocent and we are confident a jury will agree.”

During a hearing before a federal magistrate judge Tuesday morning, the company and Sandel pleaded not guilty to the charges. Jury selection in the case was set for March 29.

According to prosecutors and the indictment, Sandel and DuPont engineers allegedly devised a plan to divert a large volume of methyl mercaptan gas into a waste gas pipe system during the day before and night of the fatal incident. However, Sandel failed to implement necessary procedures to evaluate safety aspects of that plan, according to prosecutors.

The unit where the workers died did not having adequate ventilation or air monitoring to ensure employee safety, and procedures weren’t followed that would have restricted worker access into areas where ventilation fans weren’t working, according to an investigation by the U.S. Chemical Safety Board.

I covered this incident on the blog. It's hard to believe it's been 6 years. 

I'll have to understand the government's case before I comment on it much further, i.e. why the diversion plan was unsafe, and why they're holding DuPont and plant management criminally responsible for the safety aspects. Definitely a good reminder that plant safety has real consequences, both immediate and long-term. 

Friday, January 22, 2021

Have a good weekend

 

Well, we made it to the weekend yet again. I hope it's not too rainy or snowy where you are. See you on Monday! 

How do you make a COVID vaccine?

For those like me who are fascinated by the supply chain of the mRNA COVID vaccines, this article by Jonas Neubert is quite good: 

Welcome to the bottleneck of mRNA vaccine production! The number of people in the world who know how to get lipids and mRNA to combine into a lipid nanoparticle (LNP) might be in the low hundreds. And the machines to do it might not be machines at all but one-off lab bench setups like the one in this Wall Street Journal article. 

The problem at hand is this: How do you get the four lipids and the mRNA to combine in such a way that they form the protective sphere of the LNP, in a reproducible way? You can’t just combine all parts in your Vitamix and run the smoothie program. Well, you could, but it’s not going to give you a weird smoothie and not mRNA filled lipid nano-particles. What is of the essence is precise control of molecule sizes, precise control of flow rates, and probably precise control of many other parameters. Microfluidics is the technology of choice for these requirements and are most likely used for nanoparticle formation in mRNA vaccine making.

The author is not a scientist, so there are small errors in language, etc. But it's quite good, and collects a lot of information in a single place. Worth a read.

Wednesday, January 20, 2021

"Sunset over the Rhone", Adam Cook, 2020

Credit: "Sunset over the Rhone", Adam Cook, 2020, Cologne, Germany


























Biography: Adam is a third year PhD student at the University of Ottawa, investigating nickel-catalyzed C-O activation in the lab of Prof. Stephen Newman. In his spare time (because that's totally a thing in grad school), he seeks to bridge the gap between chemistry and creativity through painting. For more on his contributions to both art and science, pay a visit to his website at www.thechempire.com

Would you like your work to be featured? E-mail Chemjobber at chemjobber@gmail.com

Smell tests for COVID?

Via the New York Times: 

...some scientists think that a quick test consisting of little more than a stinky strip of paper might at least get us close. The test does not look for the virus itself, nor can it diagnose disease. Rather, it screens for one of Covid-19’s trademark signs: the loss of the sense of smell. 

...Daniel Larremore, an epidemiologist at the University of Colorado, Boulder, and the study’s lead author, stressed that his team’s work was still purely theoretical. Although some smell tests are already in use in clinical and research settings, the products tend to be expensive and laborious to use and are not widely available. 

And in the context of the pandemic, there is not yet real-world data to support the effectiveness of smell tests as a frequent screen for the coronavirus. Given the many testing woes that have stymied pandemic control efforts so far, some experts have been doubtful that smell tests could be distributed widely enough, or made sufficiently cheat-proof, to reduce the spread of infection.

I think I'd rather do a smell test than a temperature screening, but it depends on the smell! (It would be interesting to know how many of the people who are described as 'asymptomatic' have mild anosmia.)

Tuesday, January 19, 2021

The 2021 Faculty Jobs List: 252 research/teaching positions and 31 teaching faculty positions

The 2021 Chemistry Faculty Jobs List (curated by Andrew Spaeth and myself) has 252 research/teaching positions and 31 teaching assistant professor positions.

Want to help out? Here's a Google Form to enter positions.

In 2020-2021, we will be adding teaching professor positions, targeting positions that demonstrate an intention to renew permanently, 3 year terms and a promotion ladder and/or are titled "assistant teaching professor" or "associate teaching professor." We are adding community college positions if they explicitly offer tenure.

On January 21, 2020, the 2020 Chemistry Faculty Jobs List had 521 research/teaching positions and 54 teaching faculty positions.

To see trending, go to Andrew Spaeth's visualization of previous years' list.

Want to talk anonymously? Have an update on the status of a job search? This will be the fourth open thread at noon Eastern on Tuesday, January 19. Go to the third open thread. Click here for the second thread, which closed on December 22. Don't forget to click on "load more" below the comment box for the full thread. 

The Chemical Engineering Faculty Jobs List: 50 positions

The Chemical Engineering Faculty Jobs List has 50 positions. It is curated by Lilian Josephson (@lljosephson).

From Dr. Josephson: This year we will try to utilize the list further by circulating among the professors, as well as using the hashtags #facultychemEjobs and #MeettheCandidatesChE2020.

The open thread is found here. 

The Academic Staff Jobs List: 91 positions

The Academic Staff Jobs list has 91 positions.

This list is curated by Sarah Cady and @nmr_chemist. It targets:
  • Full-time STAFF positions in a Chem/Biochem/ChemE lab/facility at an academic institution/natl lab
  • Lab Coordinator positions for research groups or undergraduate labs 
  • and for an institution in Canada or the United States
Want to help out? Here's a Google Form to enter positions.

Want to chat about staff scientist positions? Try the open thread.

Monday, January 18, 2021

US government charges MIT engineering professor

Via WBUR, this news about an MIT professor:

An MIT professor was arrested Thursday morning on federal charges that he failed to disclose ties to the Chinese government as he sought — and was awarded — research grants from the U.S. government.

U.S. Attorney Andrew Lelling said its charges against Gang Chen — paired with similar charges filed last summer against Harvard chemistry professor Charles Lieber — represent his office's attempt to counter the Chinese government's effort to "siphon off U.S. technology instead of doing the work themselves."

The charges focus on Chen's behavior since 2012, while he was running a laboratory focused on nanotechnology and energy transfer.

Chen served as chair of M.I.T.'s department of mechanical engineering from 2013 to 2018. Meanwhile, his laboratory attracted over $19 million in grants from federal agencies like the Department of Defense and the Department of Energy, according to the complaint.

Here's the full charging document; here's the press release. 

Pretty clear that the United States government is looking very carefully at business and financial ties of STEM professionals who work in both the US and China. It will be interesting to see if this continues to be a major thrust in the Biden Administration.* 

*A brief bit of political punditry: it's hard for me to imagine that the policy of a Clinton Justice Department would have been any different than that of the Trump Administration when it comes to this case, or that of Professor Lieber. 

ICIS: German chemical plants don't want to shut down for COVID lockdown

From ICIS: 

LONDON (ICIS)--Germany’s top chemical industry trade groups are rejecting calls to shut down plants as part of the country’s “hard lockdown” to contain the second wave of the coronavirus pandemic.

“A shutdown would be counter-productive, in all respects”, chemical producers group VCI and employers group BAVC said in a joint statement on Friday.

The chemical-pharmaceutical industry makes “key contributions” to containing the pandemic, the trade groups said,  in vaccine production, the manufacture of essential medicines or as the most important upstream supplier for diagnostics, medical, and laboratory equipment manufacturers.

As such, a shutdown would “considerably weaken” the fight against the coronavirus.

Furthermore, the closure of companies or plants could not be justified on an economic or commercial basis.

“Without chemical supplies, the entire industry and thus almost 30% of our economy would stand still”, they said.

Some German politicians have called for companies to increase “working from home”, and they urged to consider the closure of industrial plants in order to contain the virus.

I genuinely have a difficult time seeing a chemical plant (any chemical plant) as being a major speader of COVID, but I suspect that spread amongst operators and other employees happens in changing rooms and the like. 

Friday, January 15, 2021

Have a great weekend

 

Well, we made it to the weekend. I hope that your week was relatively stress-free and that you have a great Saturday and Sunday. See you on Monday. 

Tech leaving the Bay Area

Via the New York Times, a pretty interesting article about tech entrepreneurs leaving the Bay Area for elsewhere, with numbers to show for it: 

...The biggest tech companies aren’t going anywhere, and tech stocks are still soaring. Apple’s flying-saucer-shaped campus is not going to zoom away. Google is still absorbing ever more office space in San Jose and San Francisco. New founders are still coming to town.

But the migration from the Bay Area appears real. Residential rents in San Francisco are down 27 percent from a year ago, and the office vacancy rate has spiked to 16.7 percent, a number not seen in a decade.

Though prices had dropped only slightly, Zillow reported more homes for sale in San Francisco than a year ago. For more than a month last year, 90 percent of the searches involving San Francisco on moveBuddha were for people moving out.

Twitter, Yelp, Airbnb and Dropbox have tried to sublease some of their San Francisco office space. Pinterest, which has one of the most iconic offices in town, paid $90 million to break a lease for a site where it planned to expand. And companies like Twitter and Facebook have announced “work from home forever” plans...

I have long asserted that the Bay Area's dominance in the American life sciences space will continue unchecked, and it would take an epic natural disaster to change that. While I don't think the pandemic measures up, it certainly is doing its part to push people elsewhere. I still think that San Francisco will maintain its pre-eminence (1A to Boston's #1, IMO), but we shall see. 

It would be interesting to know who exactly is leaving, i.e. the people who were successful in tech entrepreneurship, or those who were not? 

Thursday, January 14, 2021

Want to see some recent starting salaries?

From a recently hired entry-level PhD organic chemist (let's call them HQN), this helpful information: 

Small/med pharma - med chem, SF: was quoted at 110-120k typical base pay, plus relocation (amount unknown)

Small pharma Boston, med chem and process: 90-100k (medium confidence on this one, this is thru the grapevine for previous hires within past few years, but nothing current right now)

Large pharma companies, med chem or process positions, Boston, Philly, Bay Area, Chicago: 115-120k base for very competitive applicants. Offers also typically included some type of sign-on bonus (10k+), as well as relo. I know a few people that fell into this category, and they were really lucky because they had multiple offers in hand and let companies actively ‘bid’ against one another.

Before receiving offers, these individuals were quoted at “97-115k” for typical base salaries.

CMO, [redacted], process: (90k?)-100k base, plus very generous relocation. (100k base was my offer, but i got stuck in the “whoever goes first, loses” camp. I did get to name my price and they met it. Glassdoor said that the range was more like 80-90k, so I thought my ask was decent. Probably could have gotten more but alas… idk how much more I could have actually gotten anyway, and without another offer immediately in hand, I kinda felt I didn't have good leverage to ask for more now. I am assuming that 90k is actual low end of the range here, but not confident on that. 

Small pharma NJ, med chem: ~92k base, 5k signing bonus in lieu of relocation.

For context, I would suggest that those who are entertaining offers really consider relocation vs signing bonus (ideally, one could negotaite for both, but if foregoing relo, think VERY hard about the actual relocation costs associated). I've heard general murmurings that sometimes companies will forego relocation packages (something to do with setting a precedent for them? idk), in lieu of a sign on bonus. I had originally thought that the NJ offer was decent, but i turned it down just because it wasnt the right company for me. In hindsight, my current relo is lavish, and the 'signing bonus' from other company would have basically ONLY covered my lease break and nothing else. 

CMO, Boston suburbs, salary range quoted was around ~80-85k iirc. I had originally asked HR for 100-110, and they said that salary would be for someone 1-2 levels above entry level PhD - their rationale was “we’re in the suburbs so CoL is different” but that still struck me as low for the greater Boston metro area.

Thanks to HQN for their kind contribution! Readers, would you like to contribute? You can add in the comments, or e-mail me at chemjobber@gmail.com